Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Trajectory of fatigue severity in natalizumab treated multiple sclerosis patients.
Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis.
Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis.
Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.
Similar genetics of adult and pediatric MS: Age is just a number.
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People.
Immune surveillance and response to JC virus infection and PML.
Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapy.
EBV-Associated Cancer and Autoimmunity: Searching for Therapies.
Atypical Optic Neuritis.
Decrease in newly generated oligodendrocytes leads to motor dysfunctions and changed myelin structures that can be rescued by transplanted cells.
Normative data and long-term test-retest reliability of the triple stimulation technique (TST) in multiple sclerosis.
Automated White Matter Hyperintensity Detection in Multiple Sclerosis Using 3D T2 FLAIR.
Simvastatin Treatment of Patients With Acute Optic Neuritis
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.
Historical changes of seasonal differences in the frequency of multiple sclerosis clinical attacks: a multicenter study.
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.
Epstein-Barr virus and multiple sclerosis: association or causation?
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Cerebral arterial and venous blood flow in adolescent multiple sclerosis patients and age-matched controls using phase contrast MRI.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
Preliminary evaluation of variable compliance joystick for people with multiple sclerosis.
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.
Pages
« first
‹ previous
…
382
383
384
385
386
387
388
389
390
…
next ›
last »